Dr David Charles Gimarc, MD | |
126056 E. 16th Avenue, Aurora, CO 80045-2527 | |
(720) 848-0000 | |
Not Available |
Full Name | Dr David Charles Gimarc |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 11 Years |
Location | 126056 E. 16th Avenue, Aurora, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407199730 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 62229 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Colorado Hospital Authority | Aurora, CO | Hospital |
Uchealth Highlands Ranch Hospital | Highlands ranch, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Physicians Incorporated | 3476465667 | 2657 |
Uchealth Imaging Services Llc | 5799021291 | 141 |
News Archive
Results from two major multi-center clinical trials presented at the Digestive Disease Week in New Orleans independently confirmed that the effects of endoscopic radiofrequency ablation (RFA) for eradicating a pre-cancerous condition of the esophagus called Barrett's esophagus are durable in the long-term. In a plenary scientific presentation titled "Endoscopic Radiofrequency Ablation for Barrett's Esophagus: Five-year Durability Outcomes from a Prospective Multi-Center Trial," patients with Barrett's esophagus were treated with endoscopic RFA using the HALO system.
Opitz C syndrome is a genetic disease that causes severe disabilities in patients and has been diagnosed in three people in the Iberian Peninsula, and sixty people in the world.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,668,598 covering the stimulation method used in the Urgent® PC Neuromodulation System.
Working at a Saint Louis University laboratory, second-year medical student Weston Gordon performed several studies investigating two novel drug therapies that may be useful in the treatment of peripheral vascular disease in patients with Type 2 diabetes.
› Verified 1 days ago
Entity Name | University Physicians Incorporated |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
Results from two major multi-center clinical trials presented at the Digestive Disease Week in New Orleans independently confirmed that the effects of endoscopic radiofrequency ablation (RFA) for eradicating a pre-cancerous condition of the esophagus called Barrett's esophagus are durable in the long-term. In a plenary scientific presentation titled "Endoscopic Radiofrequency Ablation for Barrett's Esophagus: Five-year Durability Outcomes from a Prospective Multi-Center Trial," patients with Barrett's esophagus were treated with endoscopic RFA using the HALO system.
Opitz C syndrome is a genetic disease that causes severe disabilities in patients and has been diagnosed in three people in the Iberian Peninsula, and sixty people in the world.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,668,598 covering the stimulation method used in the Urgent® PC Neuromodulation System.
Working at a Saint Louis University laboratory, second-year medical student Weston Gordon performed several studies investigating two novel drug therapies that may be useful in the treatment of peripheral vascular disease in patients with Type 2 diabetes.
› Verified 1 days ago
Entity Name | Uchealth Imaging Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396210902 PECOS PAC ID: 5799021291 Enrollment ID: O20190103002022 |
News Archive
Results from two major multi-center clinical trials presented at the Digestive Disease Week in New Orleans independently confirmed that the effects of endoscopic radiofrequency ablation (RFA) for eradicating a pre-cancerous condition of the esophagus called Barrett's esophagus are durable in the long-term. In a plenary scientific presentation titled "Endoscopic Radiofrequency Ablation for Barrett's Esophagus: Five-year Durability Outcomes from a Prospective Multi-Center Trial," patients with Barrett's esophagus were treated with endoscopic RFA using the HALO system.
Opitz C syndrome is a genetic disease that causes severe disabilities in patients and has been diagnosed in three people in the Iberian Peninsula, and sixty people in the world.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,668,598 covering the stimulation method used in the Urgent® PC Neuromodulation System.
Working at a Saint Louis University laboratory, second-year medical student Weston Gordon performed several studies investigating two novel drug therapies that may be useful in the treatment of peripheral vascular disease in patients with Type 2 diabetes.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr David Charles Gimarc, MD 12631 E 17th Ave, Ms 8200, Aurora, CO 80045-2527 Ph: (303) 724-1980 | Dr David Charles Gimarc, MD 126056 E. 16th Avenue, Aurora, CO 80045-2527 Ph: (720) 848-0000 |
News Archive
Results from two major multi-center clinical trials presented at the Digestive Disease Week in New Orleans independently confirmed that the effects of endoscopic radiofrequency ablation (RFA) for eradicating a pre-cancerous condition of the esophagus called Barrett's esophagus are durable in the long-term. In a plenary scientific presentation titled "Endoscopic Radiofrequency Ablation for Barrett's Esophagus: Five-year Durability Outcomes from a Prospective Multi-Center Trial," patients with Barrett's esophagus were treated with endoscopic RFA using the HALO system.
Opitz C syndrome is a genetic disease that causes severe disabilities in patients and has been diagnosed in three people in the Iberian Peninsula, and sixty people in the world.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,668,598 covering the stimulation method used in the Urgent® PC Neuromodulation System.
Working at a Saint Louis University laboratory, second-year medical student Weston Gordon performed several studies investigating two novel drug therapies that may be useful in the treatment of peripheral vascular disease in patients with Type 2 diabetes.
› Verified 1 days ago
Dr. Tyler Robin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1665 Aurora Ct, Suite 1032, Msf706, Aurora, CO 80045 Phone: 720-848-0100 | |
Dr. Ryan Michael Lanning, M.D., PHD. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1665 Aurora Ct, Suite 1032, Aurora, CO 80045 Phone: 720-848-0100 Fax: 720-848-0113 | |
Stephanie C Hsu, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Thomas Suby-long, MD Radiology Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Alan E Evans, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Ajay Agarwal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Eugene E Bourne, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 6428 S Blackhawk Way, Aurora, CO 80016 Phone: 720-870-5109 |